Deals
US firm PaxVax scores USD22 million in Series B for late-stage cholera vaccine
California-based pharmaceutical company PaxVax Inc raised USD22 million in a Series B funding round for the late-stage trial of its single-dose oral cholera vaccine for travelers.
TDR Capital to exit 8% stake in British life insurer Phoenix Group
Private equity firm TDR Capital will sell half of its entire stake in insurance company Phoenix Group for about GBP127 million. TDR will sell 18 million shares out of its total 35.9 million shares in Phoenix.
Cambridge fat-burning drug maker Zafgen nabs USD45 million in Series E funding
Cambridge-based anti-obesity drug developer Zafgen Inc bagged another USD45 million in a Series E funding round today, bringing its total funding to date to USD114 million.
Private equity investors still bullish on Indian real estate - report
A report from Cushman & Wakefield revealed that the private equity industry is still optimistic on the Indian real estate market, with private equity deals in the sector increasing 26% in the first nine months of this year.




